loader image
Sunday, December 21, 2025
72.8 F
McAllen
- Advertisement -

A Simple Colonoscopy Can Save Your Life

Health & Lifestyle
334

Translate to Spanish or other 102 languages!

A routine screening for colorectal cancer beginning at age 45 can save lives! Image for illustration purposes
A routine screening for colorectal cancer beginning at age 45 can save lives! Image for illustration purposes

Mega Doctor News

- Advertisement -

By Texas Tech University Health Sciences Center El Paso

Newswise — A routine screening for colorectal cancer beginning at age 45 can save lives! In cancers that affect both men and women, colorectal cancer is the second leading cancer killer—but most cases can be prevented with routine screening tests.

Colorectal cancer usually starts from precancerous polyps in the colon or rectum. Over time, some polyps can turn into cancer.

- Advertisement -

Screening tests aid in finding precancerous polyps, so they can be removed before they turn into cancer. Screening tests can also find colorectal cancer early, when treatment works best.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Nursing Grad Gets a Life Lesson In Compassion
Next article
Let The Patient Choose Their Type 2 Diabetes Meds

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.

Early Findings Show Breast Cancer Vaccine Produces Immune Response

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine. 
- Advertisement -

We feature articles about leading professionals in the medical and healthcare industry in the South Texas area. We are your connection to the medical community!

Pick up a copy of our publication on more than 800 locations Valley-wide.

Contact Us

Office (956) 928-1255

Sales (956) 451-4585

info@tbbmega.com

sales@tbbmega.com

Subscribe

© Mega Doctor News 2025

×